Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Eby

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
British Journal of Haematology|February 13, 2009
Pathogenesis and management of bleeding and thrombosis in plasma cell dyscrasiasCharles Eby
Seminars in Thrombosis and Hemostasis|October 11, 2012
Warfarin pharmacogenetics: does more accurate dosing benefit patients?Charles Eby
Clinics in Laboratory Medicine|August 12, 2009
Antiphospholipid syndrome reviewCharles Eby
Current Hematology Reports|August 23, 2003
Hemostatic complications associated with paraproteinemiasCharles Eby, Morey Blinder
Clinics in Laboratory Medicine|May 15, 2026
An Overview of Dysfibrinogenemia: Pathogenesis, Diagnosis, and ManagementChristine Fuja, Charles Eby
Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians|February 23, 2007
Clotting profiles and selected hematology of captive Speke's gazelles (Gazella spekei)Erika K Travis, Charles Eby
Pharmacogenomics|July 15, 2005
The pharmacogenetics of coumarin therapyDeepak Voora, Howard L McLeod, Charles Eby, et al.
Drugs of Today (Barcelona, Spain : 1998)|May 19, 2004
Use of pharmacogenetics to guide warfarin therapyDeepak Voora, Howard L McLeod, Charles Eby, et al.
Transfusion|August 21, 2004
Transfusion medicine service policies for recombinant factor VIIa administrationLawrence Tim Goodnough, Douglas M Lublin, Lini Zhang, et al.
Thrombosis and Haemostasis|December 24, 2003
Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarinBrian F Gage, Charles Eby, Paul E Milligan, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
British Journal of Haematology|February 13, 2009
Pathogenesis and management of bleeding and thrombosis in plasma cell dyscrasiasCharles Eby
Seminars in Thrombosis and Hemostasis|October 11, 2012
Warfarin pharmacogenetics: does more accurate dosing benefit patients?Charles Eby
Clinics in Laboratory Medicine|August 12, 2009
Antiphospholipid syndrome reviewCharles Eby
Current Hematology Reports|August 23, 2003
Hemostatic complications associated with paraproteinemiasCharles Eby, Morey Blinder
Clinics in Laboratory Medicine|May 15, 2026
An Overview of Dysfibrinogenemia: Pathogenesis, Diagnosis, and ManagementChristine Fuja, Charles Eby
Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians|February 23, 2007
Clotting profiles and selected hematology of captive Speke's gazelles (Gazella spekei)Erika K Travis, Charles Eby
Pharmacogenomics|July 15, 2005
The pharmacogenetics of coumarin therapyDeepak Voora, Howard L McLeod, Charles Eby, et al.
Drugs of Today (Barcelona, Spain : 1998)|May 19, 2004
Use of pharmacogenetics to guide warfarin therapyDeepak Voora, Howard L McLeod, Charles Eby, et al.
Transfusion|August 21, 2004
Transfusion medicine service policies for recombinant factor VIIa administrationLawrence Tim Goodnough, Douglas M Lublin, Lini Zhang, et al.
Thrombosis and Haemostasis|December 24, 2003
Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarinBrian F Gage, Charles Eby, Paul E Milligan, et al.
Pageof 3